MetaCap

Diebold Nixdorf Incorporated (DBD)

NYSE: DBDMiscellaneousOffice Equipment/Supplies/ServicesUSD

51.86+1.59 (+3.16%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

DBD stock chart

Technical analysis

Key statistics

All statistics
52-week range
49.77 – 92.09
Day range
49.92 – 52.07
Volume / Avg
515.34K / 297.52K
Beta
—

52-week range

$49.77$92.09

DBD stock today

Diebold Nixdorf (DBD) closed at $51.86 on Nov 20, up 3.16% (+$1.59), versus the S&P 500's 3.70% decline. At this level, DBD sits near the bottom of its 52-week range of $49.77 to $92.09: 43.7% below the high, set on Jul 27, 2026 and 4.2% above the low. DBD is down 23.6% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 15.9%.

At 24.6x trailing earnings, Diebold Nixdorf trades above the peer-group median of 14.1x. Its forward P/E of 8.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Diebold Nixdorf

Company profile

Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide. It operates through two segments, Banking and Retail. The company offers automated teller machines, cash recyclers, dispensers, teller automation tools, and kiosk technologies.

Industry
Office Equipment/Supplies/Services
CEO
Mr. Octavio Marquez
Headquarters
North Canton, OH
Employees
20,000
IPO year
2023

Financial highlights

Full financials

In fiscal 2025, Diebold Nixdorf generated $3.81 billion in revenue, up 1.5% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $94.6 million, for a net margin of 2.5% versus a median of -6.9% in the prior 5 years. Gross margin was 25.3% (up from 24.5%) and operating margin 6.4%.

Diebold Nixdorf annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2022FY 2021FY 2020
Revenue$3.81B$3.75B$3.46B$3.91B$3.90B
Growth+1.46%+8.39%-11.38%+0.07%-11.49%
Net income$94.60M$-16.50M$-581.40M$-78.80M$-269.10M
EPS (diluted)$2.54$-0.44$-7.36$-1.01$-3.47

Analyst forecast

Forecast

Consensus (3 analysts)

strong_buy

Avg. price target

$85.00+63.90%

  • Strong buy 1
  • Buy 2
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $80.00High $90.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 28, 2026
EPS actual vs est.
$0.19 vs $1.31
Surprise
-85.50%

DBD news

All DBD news

Diebold Nixdorf peers

Miscellaneous sector
DBD peer companies
CompanyPrice% ChgMarket capCompare
PBIPitney Bowes Inc.14.62-0.34%$1.98Bvs DBD
MLKNMillerKnoll Inc.19.82-1.69%$1.36Bvs DBD
VYXNCR Voyix Corporation9.20-3.06%$1.25Bvs DBD
PARPAR Technology Corporation20.60-1.86%$852.24Mvs DBD
EBFEnnis Inc.19.86-1.34%$502.81Mvs DBD
JXGJX Luxventure Group Inc.14.54+8.51%$245.14Mvs DBD
HNIHNI Corporation47.82-0.95%$3.46Bvs DBD
BRAGBragg Gaming Group Inc.0.589-9.40%$18.31Mvs DBD

Diebold Nixdorf stock FAQ

What is Diebold Nixdorf's stock price today?

DBD last traded at $51.86 as of Nov 20, 4:00 PM EST, up 3.16% on the day. Prices are delayed at least 15 minutes.

What is DBD's P/E ratio?

DBD trades at a trailing P/E ratio of 24.58 and a forward P/E of 8.45, compared with a median of 14.1 for its closest peers.

Who is Diebold Nixdorf's CEO?

Mr. Octavio Marquez is the chief executive officer of Diebold Nixdorf Incorporated, which has about 20,000 employees.

What is the DBD 52-week high?

The 52-week high for DBD is $92.09 and the 52-week low is $49.77. The stock is currently 43.7% below its high.

Compare DBD